Overseas weight loss drug leader Novo Nordisk is expected to increase its annual operating profit by 40% to 46% at a constant exchange rate
Katlyn30590
发表于 2023-10-13 22:11:00
1285
0
0
Overseas weight loss drug leader Novo Nordisk is expected to increase its annual operating profit by 40% to 46% at a constant exchange rate.
CandyLake.com is an information publishing platform and only provides information storage space services.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
转播
You may like
- American pharmaceutical company Anjin's weight loss pills have attracted attention, and Novo Nordisk's stock price has fallen by 5%
- Earning too much! US Senators indirectly pressure Novo Nordisk to lower the price of weight loss pills
- "Weight loss pills" are sold in limited quantities in China? Novo Nordisk's latest response
- Oral "weight loss medication" further advances Novo Nordisk oral semaglutide weight loss phase III research success
- Lilly weight loss pills are crazily chasing after semaglutide
- The US dollar is entering a period of strength! Goldman Sachs changes its bearish view in the past two years: Trump tariffs will boost exchange rates
- Top 20 US stock transactions: Eli Lilly rises over 4%, Biden administration plans to include weight loss drugs in healthcare and subsidy programs
- After more than two years, there is finally no shortage of Zepbound, a weight loss medication from Eli Lilly
- Exchange rates plummet, Japan and South Korea urgently intervene to 'rescue the market'! A major storm has swept through the global exchange rate market
- Lilly weight loss pills are now available for purchase on e-commerce platforms. Lilly China responds that they are self funded drugs
